Andrew Beggs
Overview
Explore the profile of Andrew Beggs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
769
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cartwright L, Scerif G, Oliver C, Beggs A, Stockton J, Wilde L, et al.
Behav Brain Res
. 2025 Mar;
485:115527.
PMID: 40054504
Despite being a monogenic condition, individual variability in the phenotypic profile of fragile X syndrome (FXS) is substantial, with behavioural outcomes differing in severity and frequency. Existing studies have revealed...
2.
Campos-Leon K, Ferguson J, Gunther T, Wood C, Wingett S, Pekel S, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012506.
PMID: 39869645
Upon infection, human papillomavirus (HPV) manipulates host cell gene expression to create an environment that is supportive of a productive and persistent infection. The virus-induced changes to the host cell's...
3.
Quraishi M, Cheesbrough J, Rimmer P, Mullish B, Sharma N, Efstathiou E, et al.
J Crohns Colitis
. 2024 Dec;
19(2).
PMID: 39673746
Background: We conducted a single-arm interventional study, to explore mucosal changes associated with clinical remission under oral vancomycin (OV) treatment, in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD); NCT05376228. Methods:...
4.
Clark S, Cuthill V, Hawkins J, Hyer W, Latchford A, Sinha A, et al.
BJC Rep
. 2024 Nov;
1(1):10.
PMID: 39516584
No abstract available.
5.
Starkey T, Ionescu M, Tilby M, Little M, Burke E, Fittall M, et al.
Sci Rep
. 2023 Jul;
13(1):11327.
PMID: 37491478
Patients with cancer are at increased risk of hospitalisation and mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the SARS-CoV-2 phenotype evolution in patients with cancer since...
6.
Kumar A, Quraishi M, Al-Hassi H, El-Asrag M, Segal J, Jain M, et al.
Front Microbiol
. 2023 Apr;
14:1134105.
PMID: 37007510
Introduction: Bile acid diarrhoea (BAD) is a common disorder that results from an increased loss of primary bile acids and can result in a change in microbiome. The aims of...
7.
Hadzhiev Y, Wheatley L, Cooper L, Ansaloni F, Whalley C, Chen Z, et al.
Dev Cell
. 2023 Jan;
58(2):155-170.e8.
PMID: 36693321
In anamniote embryos, the major wave of zygotic genome activation starts during the mid-blastula transition. However, some genes escape global genome repression, are activated substantially earlier, and contribute to the...
8.
Lee L, Tilby M, Starkey T, Ionescu M, Burnett A, Hattersley R, et al.
JAMA Oncol
. 2022 Dec;
9(2):188-196.
PMID: 36547970
Importance: Accurate identification of patient groups with the lowest level of protection following COVID-19 vaccination is important to better target resources and interventions for the most vulnerable populations. It is...
9.
Panetti S, McJannett N, Fultang L, Booth S, Gneo L, Scarpa U, et al.
Blood Adv
. 2022 Dec;
7(9):1754-1761.
PMID: 36521029
Cancer cells take up amino acids from the extracellular space to drive cell proliferation and viability. Similar mechanisms are applied by immune cells, resulting in the competition between conventional T...
10.
Lee L, Ionescu M, Starkey T, Little M, Tilby M, Tripathy A, et al.
Eur J Cancer
. 2022 Sep;
175:1-10.
PMID: 36084618
Purpose: People living with cancer and haematological malignancies are at an increased risk of hospitalisation and death following infection with acute respiratory syndrome coronavirus 2. Coronavirus third dose vaccine boosters...